共 50 条
- [1] First placebo-controlled Study on fecal Microbiota Transplantation (FMT) in Patients with Irritable Bowel Syndrome[J]. COLOPROCTOLOGY, 2018, 40 (05) : 377 - 379Alt, Y.Brandt, J.Krammer, H.
- [2] FECAL MICROBIOTA TRANSPLANTATION IN IRRITABLE BOWEL SYNDROME WITH PREDOMINANT ABDOMINAL BLOATING: RESULTS FROM A DOUBLE BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL[J]. GASTROENTEROLOGY, 2018, 154 (06) : S130 - S130Holvoet, TomJoossens, MarieJerina, BoelensChristiaens, EvelienHeyerick, LanderVerhasselt, BrunoDe Vos, MartineHindryckx, PieterRaes, JeroenDe Looze, Danny
- [3] FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF OBESITY: A RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL[J]. GASTROENTEROLOGY, 2019, 156 (06) : S129 - S129Allegretti, Jessica R.Kassam, ZainChiang, Austin L.Mullish, Benjamin H.Carrellas, MadelineHurtado, JonathanMarchesi, JulianMcDonald, Julie A.Pechlivanis, AlexandrosBarker, Grace F.Blanco, Jesus MiguensWong, Wing FeiGeradin, YlaineSilverstein, MichaelKennedy, KevinThompson, Christopher C.
- [4] Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (11) : 2279 - 2285Nee, JudyBallou, SarahKelley, John M.Kaptchuk, Ted J.Hirsch, WilliamKaton, JesseCheng, VivianRangan, VikramLembo, AnthonyIturrino, Johanna
- [5] Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials[J]. FRONTIERS IN MEDICINE, 2022, 9Samuthpongtorn, ChatpolKantagowit, PiyawatPittayanon, RapatPatcharatrakul, TanisaGonlachanvit, Sutep
- [6] FECAL MICROBIOTA TRANSPLANTATION IN IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW OF RANDOMIZED-CONTROLLED TRIALS[J]. GASTROENTEROLOGY, 2019, 156 (06) : S463 - S464Pimentel, MayaLakhoo, KrutikaRezaie, Ali
- [7] Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial[J]. Microbiome, 13 (1)Luyun FanJunru ChenQi ZhangJie RenYouren ChenJinfeng YangLu WangZihong GuoPeili BuBingpo ZhuYanyan ZhaoYang WangXiaoyan LiuWenjie WangZhenzhen ChenQiannan GaoLemin ZhengJun Cai
- [8] A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF FECAL MICROBIOTA TRANSPLANTATION CAPSULES (FMTC) FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D)[J]. GASTROENTEROLOGY, 2018, 154 (06) : S154 - S155Aroniadis, Olga C.Brandt, Lawrence J.Oneto, CaterinaFeuerstadt, PaulSherman, AlexWolkoff, Allan W.Downs, Ian A.Zanetti-Yabur, AlanaRamos, YolandaCotto, Candace L.Kassam, ZainElliott, Ryan J.Rosenbaum, RobertBudree, ShrishSadovsky, Rotem GuraTimberlake, SoniaSwanson, PaigeKim, MimiKeller, Marla J.
- [9] The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial[J]. SCIENTIFIC REPORTS, 2018, 8Sun, Yi-YuanLi, MingLi, Yue-YueLi, Li-XiangZhai, Wen-ZheWang, PengYang, Xiao-XiaoGu, XiangSong, Li-JinLi, ZhenZuo, Xiu-LiLi, Yan-Qing
- [10] The fragility of randomized placebo-controlled trials for irritable bowel syndrome[J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (08)Williams, MaryJane O.Sedarous, MaryDennis, BrittanyDlamini, VanessaNwaiwu, ObiomaNguyen, LindaOkafor, Philip N.